Literature DB >> 16174859

Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.

Göran Jönsson1, Pär-Ola Bendahl, Therese Sandberg, Azra Kurbasic, Johan Staaf, Lone Sunde, Dorthe G Crüger, Christian Ingvar, Håkan Olsson, Ake Borg.   

Abstract

An estimated 10% of all cutaneous malignant melanoma (CMM) cases are inherited, but the genetics of familial CMM are largely unknown. Ocular malignant melanoma (OMM), which is rare, may be associated with familial CMM. We performed a genome-wide scan of two Danish pedigrees with multiple cases of OMM (N = 10) and CMM (N = 3) and other malignancies (with no germline mutations in CDKN2A, CDK4, BRCA1, and BRCA2) to identify melanoma susceptibility genes. Results of parametric linkage analysis are presented as logarithm of the odds (LOD) scores, and all P values are two-sided. Peak two-point parametric LOD score of 2.2 (P = .0007) at D9S167 on chromosome 9q21 was observed. Targeted analysis of a third Danish family with OMM and CMM patients confirmed 9q21 linkage, providing a combined four-point parametric LOD score of 3.02 (nominal P = .00003 and genome-wide P = .086). Two families shared a common haplotype comprising three adjacent and highly polymorphic markers, limiting the region to less than 5 cM and 3 Mbp at 9q21.32. Expression of RASEF, a known gene in this region, was examined in tumor tissue from 10 sporadic CMM lesions and was found to be decreased in 70% of these tumors compared with RASEF expression in a human reference RNA pool from 10 different cell types and in 10 breast tumors.

Entities:  

Mesh:

Year:  2005        PMID: 16174859     DOI: 10.1093/jnci/dji280

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition.

Authors:  Mohamed H Abdel-Rahman; Robert Pilarski; James B Massengill; Benjamin B Christopher; Frederick H Davidorf
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma.

Authors:  Craig C Teerlink; Chad Huff; Jeff Stevens; Yao Yu; Sheri L Holmen; Mark R Silvis; Kirby Trombetti; Hua Zhao; Douglas Grossman; James M Farnham; Jingran Wen; Julio C Facelli; Alun Thomas; Markus Babst; Scott R Florell; Laurence Meyer; John J Zone; Sancy Leachman; Lisa A Cannon-Albright
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

3.  Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.

Authors:  Mykyta Artomov; Alexander J Stratigos; Ivana Kim; Raj Kumar; Martin Lauss; Bobby Y Reddy; Benchun Miao; Carla Daniela Robles-Espinoza; Aravind Sankar; Ching-Ni Njauw; Kristen Shannon; Evangelos S Gragoudas; Anne Marie Lane; Vivek Iyer; Julia A Newton-Bishop; D Timothy Bishop; Elizabeth A Holland; Graham J Mann; Tarjinder Singh; Mark J Daly; Hensin Tsao
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

4.  Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.

Authors:  Stéphane Larré; Philippe Camparo; Eva Comperat; Delphine Boulbés; Mohammed Haddoum; Sylvain Baulande; Pascal Soularue; Pierre Costa; Olivier Cussenot
Journal:  Asian J Androl       Date:  2011-12-26       Impact factor: 3.285

5.  Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.

Authors:  Li-E Wang; Yu-jing Huang; Ming Yin; Jeffrey E Gershenwald; Victor G Prieto; Jeffrey E Lee; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  Eur J Cancer       Date:  2010-07-23       Impact factor: 9.162

6.  Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.

Authors:  B Buecher; M Gauthier-Villars; L Desjardins; L Lumbroso-Le Rouic; C Levy; A De Pauw; J Bombled; C Tirapo; C Houdayer; B Bressac-de Paillerets; D Stoppa-Lyonnet
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

7.  Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.

Authors:  M H Abdel-Rahman; R Pilarski; S Ezzat; J Sexton; F H Davidorf
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

8.  Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma.

Authors:  Fushi Wen; Alex Shen; Reneé Shanas; Achyut Bhattacharyya; Fangru Lian; Galen Hostetter; Jiaqi Shi
Journal:  Ann Surg Oncol       Date:  2010-05-25       Impact factor: 5.344

Review 9.  Genetic risk factors for melanoma.

Authors:  Kathrine Damm Meyle; Per Guldberg
Journal:  Hum Genet       Date:  2009-07-08       Impact factor: 4.132

10.  Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer.

Authors:  Kristina K Lagerstedt; Johan Staaf; Göran Jönsson; Elisabeth Hansson; Christina Lönnroth; Ulf Kressner; Lars Lindström; Svante Nordgren; Ake Borg; Kent Lundholm
Journal:  Cancer Inform       Date:  2007-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.